Back to funds
View filing
BIOS Capital Management, LP
hedge fundUpdated 9 days agoManaged by Bios Capital Management, Lp • Latest filing Q3 2026
Portfolio value
$34.2B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $82.6M |
| Q1 2026 | $52.9M |
| Q2 2026 | $41.7M |
| Q3 2026 | $34.2B |
Top holdings
9 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $17.8B | 3.68M | 52.17% | — | |
| 2 | ? N/A ACTUATE THERAPEUTICS INC | $6.7B | 8.59M | 19.62% | — |
| 3 | $5.3B | 5.50M | 15.45% | — | |
| 4 | ? N/A REIN THERAPEUTICS INC | $1.4B | 1.76M | 4.14% | — |
| 5 | ? N/A ACTUATE THERAPEUTICS INC | $1.1B | 1.46M | 3.32% | — |
| 6 | ? N/A REIN THERAPEUTICS INC | $984.1M | 1.22M | 2.88% | — |
| 7 | $480.1M | 500.1K | 1.41% | — | |
| 8 | $238.3M | 235.9K | 0.70% | — | |
| 9 | ? N/A IN8BIO INC | $107.7M | 81.0K | 0.32% | — |